Archived Medical Policies
The policies below are in PDF format. If you do not have Adobe Acrobat Reader, you may download it here.
#
- 0033_HMP Empower Your Health Flyer _3232023_HAP158377_MI-MED-M-2242809
- 0033_Mileage Reimbursement Form_MI HAP CS_MI-MED-M-2211403
- 01 - Marketplace Drug Policies
- 01-Front-Cover
- 01-Front-Cover
- 01-FrontCover
- 02-Letter
- 02-Letter
- 04-About-Us
- 05-Appeals-Procedures
- 05-Appeals-Procedures
- 05.21 Clinical Policy - Ohio MCD, MP, MA - MONTHLY POSTING
- 06-Claims-Submissions
- 10-Day Quantity Limit for Prescribing Opioids
- 10-Key-Contract-Provisions
- 10-Key-Contract-Provisions
- 11-Member-Enrollment-and-Eligibility
- 112907_Y0119_GA-DSNP-M-2120906_C D-SNP 2024 (10/18/2023) Last updated on 10/18/2023
- 112907_Y0119_OH-DSNP-M-2120906_C D-SNP 2024 (10/18/2023) Last updated on 10/18/2023
- 113226_H8452_OH-MYC-M-2146350 - 2024 MyCare FULL_Directory
- 116317_H9712_MI-MMP-M-2425232 HAP CS MI Health Link FULL Provider Directory Proof
- 14-Primary-Care-Providers
- 14-Primary-Care-Providers
- 15-Day Trial for New Atypical Antipsychotic Medications
- 16-ReferralsAndPAs
- 17 Alpha Hydroxyprogesterone Caproate (Makena)
- 17 alpha hydroxyprogesterone caproate (Makena)
- 17 Alpha Hydroxyprogesterone caproate (Makena)
- 17 Alpha Hydroxyprogesterone caproate (Makena)
- 17-Supplements-Forms
- 17-Supplements-Forms
- 17P4HB1_GA_PLANNING-FOR-HEALTHY-BABIES
- 18-Back-Cover
- 18-Back-Cover
- 18-BackCover
- 20081230
- 20091230
- 2010_CareSource-Foundation_Report-web
- 2010EvidenceofCoverage-Drug Redetermination-pgs132-136
- 2010EvidenceofCoverage-DrugRedetermination-pgs132-136
- 2011-OH-NE-Region-Intro
- 2012 - 2014 CAHPS Survey Results
- 2012 - 2014 HEDIS Survey Results
- 2012 Annual Stakeholders Report
- 2012 Annual Stakeholders Report
- 2012-OH-Summary-of-Benefits-508
- 2012-StepTherapy-508
- 2013 Drugs Requiring Prior Authorization
- 2013 Drugs Requiring Prior Authorization 20130408
- 2013 Drugs Requiring Step Therapy - 508
- 2013 Quality Report Card
- 2014 ABA Therapy
- 2014 Fall Feel Good Newsletter
- 2014 KY Medicaid Drugs Requiring Prior Authorization
- 2014 KY Provider Manual About Us
- 2014 KY Provider Manual Claims Submissions
- 2014 KY Provider Manual Communicating with Humana CareSource
- 2014 KY Provider Manual Covered Services and Exclusions
- 2014 KY Provider Manual Credentialing and Recredentialing
- 2014 KY Provider Manual Key Contract Provisions
- 2014 KY Provider Manual Member Enrollment and Eligibility
- 2014 KY Provider Manual Member Support Services and Benefits
- 2014 KY Provider Manual Pharmacy
- 2014 KY Provider Manual Primary Care Providers
- 2014 KY Provider Manual Provider Appeals Procedures
- 2014 KY Provider Manual Quality Improvement Program Goals
- 2014 KY Provider Manual Quality Performance Measures
- 2014 KY Provider Manual Referrals and Prior Authorizations
- 2014 KY Provider Manual Welcome
- 2014 Over the Counter Catalog - 508
- 2014 SNP OH ANOC 508
- 2014 SNP OH Pharmacy Directory 508
- 2014 Spring Feel Good Newsletter
- 2014-SNP-OH-Plan-Ratings-H6178_OHMSNP821 508
- 2015 Annual Report
- 2015 Annual Stakeholders Report
- 2015 CAHPS Survey Annual Scores
- 2015 CareSource Just4Me Indiana Medical Benefits Chart
- 2015 CareSource Just4Me Indiana Pharmacy Comparison Chart
- 2015 CareSource Just4Me Kentucky Medical Benefits Chart
- 2015 CareSource Just4Me Kentucky Pharmacy Comparison Chart
- 2015 CareSource Just4Me Ohio Medical Benefits Chart
- 2015 CareSource Just4Me Ohio Pharmacy Comparison Chart
- 2015 Eastern KY Provider Directory
- 2015 HEDIS Survey Results Annual Rates
- 2015 Just4Me Indiana Provider Manual
- 2015 Just4Me Kentucky Provider Manual
- 2015 KY Just4Me Member Handbook
- 2015 Newsletter Production Schedule
- 2015 OH J4M Premium Rebate FAQ
- 2015 OH Medicaid Member Newsletter
- 2015 Ohio Provider Manual now available
- 2015-spring-feel-good-newsletter
- 2015/2016 MyCare Ohio Opt-In Coinsurance for SNF Claims
- 2016 Annual Report
- 2016 HIX IN Just4Me FAQs
- 2016 HIX IN Marketplace FAQs
- 2016 HIX IN Plan Comparison Doc
- 2016 HIX OH Just4Me FAQs
- 2016 HIX OH Marketplace FAQs
- 2016 HIX OH Plan Comparison Doc
- 2016 HIX WV Just4Me FAQs
- 2016 HIX WV Marketplace FAQs
- 2016 HIX WV Plan Comparison Doc
- 2016 JUST4ME DENTAL BENEFIT QUICK REFERENCE GUIDE
- 2016 Just4Me Kentucky Member Handbook
- 2016 KY HIX Just4Me FAQs
- 2016 KY HIX kynect FAQs
- 2016 KY HIX Plan Comparison Doc
- 2016 KY Med Prior Auth List MyCareSource
- 2016 Member Handbook Update Exclusions
- 2016 MyCare ANOC 508
- 2016 MyCare Bad Debt Reconciliation
- 2016 WV Just4Me Member Handbook
- 2016-par-behavioral-health
- 2016-par-free-standing-birthing-centers
- 2016-par-laboratories
- 2016-par-pharmacies
- 2016-par-radiology
- 2016-quick-reference-guide-for-non-participating-providers
- 2017 Fall KY ProviderSource Newsletter
- 2017 IN Summer ProviderSource Newsletter
- 2017 marketplace formulary
- 2017 Medicare-Medicaid Member Handbook with ANOC 508
- 2017 Medicare-Medicaid Member Handbook with ANOC 508 sp
- 2017 MP Vision Benefit QRG
- 2017 OH Diagnosis Related Group Rate Changes
- 2017 Stakeholder Report
- 2017 Summer Feel Good Newsletter
- 2017 Winter KY ProviderSource Newsletter
- 2017_CS-P-0298_NIA-Cardiac-Services-Authorization-Announcement
- 2017_OH-P-1400-V_Upcoming-Deadline-Submitting-Ohio-Medicaid-Provider-Number
- 2017-east-central-region-spanish-mycare-provpharm-directory-508
- 2017-IN-P-0317-Suspension-of-Timely-Filing-Limit-for-HHW-and-HIP
- 2017-KY-Blood-Lead-Testing-Recommendations
- 2017-ky-marketplace-formulary
- 2017-ky-newsletter-feel-good-winter
- 2017-ky-PY-0158-Glycosylated-Hemoglobin-A1C-Reimbursement-Policy
- 2017-mycare-formulary-508
- 2017-mycare-prior-authorization-drugs-508
- 2017-mycare-provider-and-pharmacy-directory-east-central-region-508
- 2017-mycare-provider-and-pharmacy-directory-northeast-central-region-508
- 2017-mycare-provider-and-pharmacy-directory-northeast-region-508
- 2017-mycare-spanish-comprehensive-formulary 508
- 2017-mycare-step-therapy-drugs-508
- 2017-mycare-summary-of-benefits-508
- 2017-mycare-summary-of-benefits-spanish-508
- 2017-north-east-central-region-spanish-mycare-provpharm-directory-508
- 2017-north-east-region-spanish-mycare-provpharm-directory-508
- 2017ma-prior-auth-criteria 508
- 2017ma-step-therapy-criteria-508
- 2017MP Medical Benefits Chart KY
- 2018 WV MP Consumer Justification Narrative
- 2018 Annual Stakeholder Report
- 2018 IN MP Consumer Justification Narrative
- 2018 KY MP Consumer Justification Narrative
- 2018 MA Enrollment Form 508
- 2018 Medicare Medicaid Member Handbook with ANOC 508
- 2018 medicare medicaid member handbook with anoc 508 sp
- 2018 MyCare Summary of Benefits 508
- 2018 MyCare Summary of Benefits 508
- 2018 MyCare Summary of Benefits Spanish 508
- 2018 OH MP Consumer Justification Narrative
- 2018 Spring Feel Good Newsletter - Spanish
- 2018-east-central-region-spanish-mycare-provpharm-directory
- 2018-east-central-region-spanish-mycare-provpharm-directory-508
- 2018-email-Y0119_OHMA_PreEnroll_Guide
- 2018-EOC-IN-Basic-FINAL
- 2018-EOC-IN-DV-FINAL
- 2018-EOC-IN-Simple-Choice-Basic-FINAL
- 2018-EOC-IN-Simple-Choice-DV-FINAL
- 2018-EOC-KY-Basic-FINAL
- 2018-EOC-KY-DV-FINAL
- 2018-EOC-KY-Simple-Choice-DV-FINAL
- 2018-EOC-KY-Simple-Choice-FINAL
- 2018-EOC-OH-Basic-EOC-FINAL
- 2018-EOC-OH-DV-FINAL
- 2018-EOC-OH-Simple-Choice-DV-FINAL
- 2018-EOC-OH-Simple-Choice-EOC-FINAL
- 2018-EOC-WV-Basic-EOC-FINAL
- 2018-EOC-WV-DV-FINAL
- 2018-EOC-WV-Simple-Choice-DV-FINAL
- 2018-EOC-WV-Simple-Choice-FINAL
- 2018-IN-Marketplace-Non-Descrimination-Tag
- 2018-in-wv-marketplace-formulary
- 2018-KY-HUCP0-0766-KY-Medicaid-Updating-Provider-Demographic
- 2018-ky-marketplace-formulary
- 2018-KY-Marketplace-Non-Descrimination-Tag
- 2018-KY-Marketplace-Off-Exchange
- 2018-mycare-spanish-comprehensive-formulary-508
- 2018-mycare-step-therapy-drugs-508
- 2018-north-east-central-region-spanish-mycare-provpharm-directory
- 2018-north-east-region-spanish-mycare-provpharm-directory
- 2018-oh-marketplace-formulary
- 2018-OH-Marketplace-Non-Descrimination-Tag
- 2018-oh-medicaid-waiver-member-handbook
- 2018-Q1_CareSource-MemberSource-Newsletter_OH
- 2018-WV-Marketplace-Non-Descrimination-Tag
- 2019 IN MP Basic EOC
- 2019 IN MP Consumer Justification Narrative
- 2019 IN MP Enhanced EOC
- 2019 IN MP member handbook
- 2019 KY MP Basic EOC
- 2019 KY MP Consumer Justification Narrative
- 2019 KY MP Enhanced EOC
- 2019 KY MP member handbook
- 2019 MA Prior Auth List
- 2019 MyCare ANOC 508
- 2019 MyCare Member Handbook - Duals
- 2019 MyCare Prior Auth List MyCareSource
- 2019 MyCare Spanish ANOC 508
- 2019 MyCare Spanish Summary of Benefits duals
- 2019 MyCare Summary of Benefits - Duals
- 2019 OH MP Basic EOC
- 2019 OH MP Enhanced EOC
- 2019 OH MP member handbook
- 2019 Pre-Enrollment Kit Medicare Adv
- 2019 WV MP Basic EOC
- 2019 WV MP Consumer Justification Narrative
- 2019 WV MP Enhanced EOC
- 2019 WV MP member handbook
- 2019-annual-stakeholder-report
- 2019-IN-marketplace-formulary
- 2019-ky-marketplace-formulary
- 2019-ma-comp-formulary
- 2019-ma-csa-anoc-eoc
- 2019-ma-csa-eoc
- 2019-ma-csap-anoc-eoc
- 2019-ma-csap-eoc
- 2019-ma-cszp-anoc-eoc
- 2019-ma-cszp-eoc
- 2019-ma-enrollment-form-508
- 2019-ma-formulary-changes-508
- 2019-ma-summary-of-benefits
- 2019-manueal-del-afiliado-de-medicare-medicaid
- 2019-mycare-formulary-508
- 2019-mycare-formulary-spanish-508
- 2019-oh-marketplace-formulary
- 2019-wv-marketplace-formulary
- 2020 D-SNP Electronic PEK
- 2020 DSNP Formulary Changes
- 2020 DSNP Summary of Benefits
- 2020 MA Formulary Changes
- 2020 MA-PD Electronic Enrollment Kit
- 2020 MyCare Coverage Determination Request Form
- 2020 MyCare Redetermination Request Form
- 2020 OH MA Coverage Determination Request Form
- 2020-dsnp-comp-formulary
- 2020-dsnp-comp-formulary-es
- 2020-dsnp-csda-eoc
- 2020-dsnp-enrollment-form
- 2020-ga-med-prior-auth-list-mycaresource
- 2020-ga-mp-basic-eoc
- 2020-ga-mp-dvf-eoc
- 2020-ga-mp-member-handbook
- 2020-in-mp-basic-eoc
- 2020-in-mp-dvf-eoc
- 2020-in-mp-member-handbook
- 2020-ky-mp-basic-eoc
- 2020-ky-mp-dvf-eoc
- 2020-ky-mp-member-handbook
- 2020-ma-comp-formulary
- 2020-ma-csa-anoc-eoc
- 2020-ma-csa-eoc
- 2020-ma-cszp-anoc-eoc
- 2020-ma-cszp-eoc
- 2020-ma-enrollment-form
- 2020-ma-prior-auth-list
- 2020-ma-sbc
- 2020-manueal-del-afiliado-de-medicare-medicaid
- 2020-marketplace-prior-authorization-list
- 2020-mycare-anoc-508
- 2020-mycare-formulary-508
- 2020-mycare-formulary-spanish-508
- 2020-mycare-prior-auth-list-mycaresource
- 2020-mycare-spanish-anoc-508
- 2020-mycare-spanish-summary-of-benefits-duals-508
- 2020-mycare-summary-of-benefits-duals
- 2020-oh-mp-basic-eoc
- 2020-oh-mp-dvf-eoc
- 2020-oh-mp-member-handbook
- 2020-ohio-medicaid-prior-authorization-list
- 2020-wv-mp-basic-eoc
- 2020-wv-mp-dvf-eoc
- 2020-wv-mp-member-handbook
- 2021 Arkansas Special Olympics Event Sponsor List
- 2021 GA MP Benefits Brochure
- 2021 GA MP Enrollment Info Card
- 2021 Georgia Health Partner Orientation
- 2021 IN MP Benefits Brochure
- 2021 IN MP Enrollment Info Card
- 2021 Kentucky Health Partner Orientation
- 2021 KY MP Benefits Brochure
- 2021 KY MP Enrollment Info Card
- 2021 Medicare Prior Authorization List
- 2021 Multi OH Annual Notice of Requirements
- 2021 OH MP Benefits Brochure
- 2021 OH MP Enrollment Info Card
- 2021 West Virginia MP Health Partner Orientation
- 2021 WV MP Benefits Brochure
- 2021 WV MP Enrollment Info Card
- 2021-marketplace-prior-authorization-list
- 2022 CareSource Foundation Grantee Guide
- 2022 DSNP PA Criteria
- 2022 MA Prior Auth List
- 2022 OH Family of Plans Brochure
- 2022-2023 Adult HEDIS Coding Guide
- 2022-marketplace-prior-authorization-list
- 2022-medicaid-quality-program-evaluation-final
- 2023 D-SNP and Ohio MyCare Model of Care Training Requirement
- 2023 D-SNP Comp Formulary_SP-508 (12/12/2023) Last updated on 12/12/2023
- 2023 D-SNP OTC Order Form
- 2023 Marketplace product filing PA listing_GA
- 2023 Marketplace product filing PA listing_IA
- 2023 Marketplace product filing PA listing_IN
- 2023 Marketplace product filing PA listing_KY
- 2023 Marketplace product filing PA listing_NC
- 2023 Marketplace product filing PA listing_OH
- 2023 Marketplace product filing PA listing_WV
- 2023 Michigan Medicaid Quality Program Evaluation
- 2023 MyCare Member Handbook
- 2023 MyCare OTC Catalog
- 2023 MyCare Prior Authorization List
- 2023 Pharmacy Network Change
- 2023-hap-empowered-medicaid-quality-program-final
- 2023-multi-marketplace-prior-authorization-list
- 2023-nc-marketplace-prior-authorization-list
- 2023-wv-marketplace-prior-authorization-list
- 2024 GA MP Supplemental Benefit Brochure
- 2024 GA Utilization Management Prior Authorization Transparency Act Report
- 2024 IN MP Benefits Brochure
- 2024 IN MP Reference Guide
- 2024 IN MP Supplemental Benefit Brochure
- 2024 KY MP Supplemental Benefit Brochure
- 2024 Marketplace Prior Authorization List - Multi
- 2024 Marketplace Prior Authorization List - NC
- 2024 Marketplace Prior Authorization List - WV
- 2024 MI HAP Provider Directory (1/31/2025) Last updated on 1/31/2025
- 2024 MI MMP Provider and Pharmacy Directory
- 2024 NC MP Benefits Brochure
- 2024 NC MP Diabetes Brochure
- 2024 NC MP Reference Guide
- 2024 NC MP Supplemental Benefit Brochure
- 2024 OH MP Benefits Brochure
- 2024 OH MP Diabetes Brochure
- 2024 OH MP Reference Guide
- 2024 OH MP Supplemental Benefit Brochure
- 2024 WI Marketplace Provider Manual
- 2024 WV MP Benefits Brochure
- 2024 WV MP Diabetes Brochure
- 2024 WV MP Reference Guide
- 2025 CareSource Prior Authorization List WV
- 2025 Clinical Quality Training Schedule - CareSource Arkansas
- 2025 Exclusion-Limitation Code list
- 2025 GA DSNP Formulary
- 2025 GA DSNP Formulary SP
- 2025 GA DSNP Provider Directory (1/31/2026) Last updated on 1/31/2026
- 2025 IN MP Utilization Management Prior Authorization Transparency Act Report
- 2025 MI MMP Formulary en
- 2025 MI MMP Formulary sp
- 2025 Multi Marketplace Prior Authorization List
- 2025 NC CareSource Prior Authorization List
- 2025 OH DSNP Provider Directory Vol 1 of 3
- 2025 OH DSNP Provider Directory Vol 2 of 3
- 2025 OH DSNP Provider Directory Vol 3 of 3
- 2025 OH MyCare Provider Directory Vol 1 of 3 (1/01/2026) Last updated on 1/01/2026
- 2025 OH MyCare Provider Directory Vol 2 of 3 (11/26/2025) Last updated on 11/26/2025
- 2025 OH MyCare Provider Directory Vol 3 of 3 (11/26/2025) Last updated on 11/26/2025
- 2025 Ohio DSNP Provider Directory (1/31/2026) Last updated on 1/31/2026
- 2025 Pharmacy Transparency Act Provider Report - GA MCD
- 2025 Pharmacy Transparency Act Report Posting - GA MP
- 2025 Q1 IN-Multi-P-2903317 Friday Forum Save the Date
- 2025-prior-authorization-list_michigan-mmp
- 2026 CareSource MyCare OH Pre Enrollment Kit - 2025-09-24_FINAL
- 2026 GA DSNP Pre Enrollment Kit Combined_FINAL
- 2026 GA DSNP Pre Enrollment Kit Combined_FINAL
- 2026 GA DSNP Pre Enrollment Kit Combined_FINAL
- 2026 GA DSNP Provider Directory (2/27/2026) Last updated on 2/27/2026
- 2026 MI HAP Provider Directory Vol 1 (3/03/2026) Last updated on 3/03/2026
- 2026 MI HAP Provider Directory Vol 2 (3/03/2026) Last updated on 3/03/2026
- 2026 MI HAP Provider Directory Vol 3 (3/03/2026) Last updated on 3/03/2026
- 2026 MI HIDE FULL DIR_vol_1
- 2026 MI HIDE FULL DIR_vol_2
- 2026 MI HIDE FULL DIR_vol_3
- 2026 MI MMP Provider and Pharmacy Directory (2/02/2026) Last updated on 2/02/2026
- 2026 MyCare Medicare and Medicaid Provider Directory Vol 1 of 3 (3/03/2026) Last updated on 3/03/2026
- 2026 MyCare Medicare and Medicaid Provider Directory Vol 2 of 3 (3/03/2026) Last updated on 3/03/2026
- 2026 MyCare Medicare and Medicaid Provider Directory Vol 3 of 3 (3/03/2026) Last updated on 3/03/2026
- 24-colts-caresource-choose_love_playbook-digital.pdf
- 270-271 Companion Guide
- 276-277 Companion Guide
- 278 Companion Guide Outbound
- 30 Day Change Notice 01012025_ v2
- 30 Day Change Notice 04012025
- 30 Day Readmission
- 30 Day Readmission
- 30 Day Readmission
- 30 Day Readmission
- 30 Day Readmission
- 30 Day Readmission
- 340B Drug Pricing
- 340B Drug Pricing
- 340B Drug Pricing
- 340B Drug Pricing
- 340B Drug Pricing
- 340B Drug Pricing
- 340B Drug Pricing
- 340B Drug Pricing
- 340B Drug Pricing - Archive on July 6, 2023
- 340B Drug Pricing Policy
- 4.1.2023 Effective GA-MMED-1760a-V.10 Member Summary of PDL Changes 508
- 4.1.2023 Effective GA-MMED-2705 Member Summary of PDL Changes -SPANISH 508
- 4.1.2023 Effective GA-P-0216a-V.17 Provider Summary of PDL Changes 508
- 5010-Claims-too-Early
- 508_IN-MMED-2405a Q3 mbrsrce nwsltr FINAL 10082018 DIGITAL Tagged
- 508_IN-MMED-2612 Q4 IN mbrsrce newsletter_V3
- 508_MemberSource Winter 2018-2019 SPANISH
- 5933-IPPP-Pregnancy Promise Program Member Handout_HAITIAN
- 5933-IPPP-Pregnancy Promise Program Member Handout_VIETNAMESE
- 6.1.2023 GA-MMED-1760a-V.11 Member Summary of PDL Changes English_WEB
- 6.1.2023 GA-MMED-2705-V.21 Member Summary of PDL Changes -SPANISH_WEB
- 6.1.2023 GA-P-0216a-V.18 Provider Summary of PDL Changes_WEB
- 67 HAP Empowered Pharmacy Reimbursement Form_Approved 712020_ MI-MED-M-2237599
- 7 Day Follow-up After Hospitalization for Mental Illness Network Notification
- 8_MI HAP CareSource HMP Copay Flier_MI-MED-M-2238280
- 834 Companion Guide Outbound
- 835 Companion Guide Outbound
- 837-I Companion Guide Outbound
- 837-P Companion Guide Outbound
- 96823_2023 MyCare Full Online Directory (12/19/2024) Last updated on 12/19/2024
A
- ABA Therapy
- Abatacept (Orencia) Injection
- Abecma (idecabtagene vicleucel) - Archived on 11/01/2025
- Abecma - Archived on 07/01/2025
- Abecma (idecabtagene vicleucel)
- Abecma (idecabtagene vicleucel)
- Abecma (idecabtagene vicleucel)
- Abecma (idecabtagene vicleucel)
- Abecma (idecabtagene vicleucel)
- Abecma (idecabtagene vicleucel)
- Abecma (idecabtagene vicleucel)
- Abecma (idecabtagene vicleucel) - Archived 10/1/2022
- Abecma (idecabtagene vicleucel) - Archived 9/30/2022
- Abecma (idecabtagene vicleucel) - Archived on 01/01/2026
- Abecma (idecabtagene vicleucel) - Archived on 02/01/2026
- Abecma (idecabtagene vicleucel) - Archived on 07/01/2025
- Abecma (idecabtagene vicleucel) - Archived on 07/01/2025
- Abecma (idecabtagene vicleucel) - Archived on 07/01/2025
- Abecma (idecabtagene vicleucel) - Archived on 07/01/2025
- Abecma (idecabtagene vicleucel) - Archived on 07/01/2025
- Abecma (idecabtagene vicleucel) - Archived on 10/01/2025
- Abecma (idecabtagene vicleucel) - Archived on 10/1/2022
- Abecma (idecabtagene vicleucel) - Archived on 10/1/2022
- Abecma (idecabtagene vicleucel) - Archived on 10/27/2025
- Abecma® (idecabtagene vicleucel intravenous infusion – Bristol-Myers Squibb and bluebird bio)
- Abecma® (idecabtagene vicleucel intravenous infusion – Bristol-Myers Squibb and bluebird bio) - Archived on 04/30/2025
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abortion
- Abraxane (paclitaxel albumin-bound suspension, intravenous infusion – Celgene, generic)
- Accommodation During Transplant Surgery
- AcknowledgmentOfReceiptOfHysterectomyInformation
- Actemra - Archived 01/01/2025
- Actemra (tocilizumab)
- Actemra (tocilizumab)
- Actemra (tocilizumab)
- Actemra (tocilizumab)
- Actemra (tocilizumab)
- Actemra (tocilizumab)
- Actemra (tocilizumab)
- Actemra (tocilizumab)
- Actemra (tocilizumab)
- Actemra (tocilizumab)
- Actemra (tocilizumab)
- Actemra (tocilizumab) - Archived 7/1/2022
- Actemra (tocilizumab) - Archived on 01/01/2025
- Actemra (tocilizumab) - Archived on 01/01/2025
- Actemra (tocilizumab) - Archived on 01/01/2025
- Actemra (tocilizumab) - Archived on 03/10/2025
- Actemra (tocilizumab) - Archived on 10/1/2022
- Actemra (tocilizumab) - Archived on 11/15/2024
- Actemra (tocilizumab) - Archived on 7/1/2022
- Actemra® (tocilizumab intravenous infusion – Genentech/Roche)
- Actemra® (tocilizumab intravenous infusion – Genentech/Roche) - Archived on 05/28/2025
- Acthar - Archived on 10/1/2024
- Acthar - Archived on 12/31/2022
- Acthar - archived on 4/21/23
- Acthar Gel
- Acthar Gel - Archived on 10/1/2024
- Acthar Gel (repository corticotropin injection) - Archived on 10/1/2024
- Acthar Gel (repository corticotropin injection)
- Acthar Gel (repository corticotropin injection)
- Acthar Gel (repository corticotropin injection)
- Acthar Gel (repository corticotropin injection)
- Acthar Gel (repository corticotropin injection)
- Acthar Gel (repository corticotropin injection)
- Acthar Gel (repository corticotropin injection)
- Acthar Gel (repository corticotropin injection)
- Acthar Gel (repository corticotropin injection) - Archive on 10/0/2024
- Acthar Gel (repository corticotropin injection) - Archived 10/03/2023
- Acthar Gel (repository corticotropin injection) - Archived 12/31/2022
- Acthar Gel (repository corticotropin injection) - Archived on 1/1/2023
- Acthar Gel (repository corticotropin injection) - Archived on 10/19/2022
- Acthar Gel (repository corticotropin injection)-archived on 1/1/23
- Acthar® Gel (repository corticotropin intramuscular and subcutaneous injection – Mallinckrodt)
- Acthar® Gel (repository corticotropin intramuscular and subcutaneous injection – Mallinckrodt) - Archived on 06/20/2025
- Actimmune (Interferon gamma-1b)
- Acupuncture Services
- Acupuncture Services
- Acupuncture Services
- Acupuncture Services
- Acupuncture Services
- Acupuncture Services
- Acupuncture Services
- Acupuncture Services
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute Hospital Care at Home
- Acute In-Patient Detoxification (Opioid) PA Criteria
- Acute In-Patient Detoxification (Opioid) PA Criteria
- Acute In-Patient Detoxification (Opioid) Prior Authorization Criteria
- Adagen (pegademase bovine) injection
- Adakveo
- Adakveo - Archived on 07/01/2024
- Adakveo (crizanlizumab-tmca)
- Adakveo (crizanlizumab-tmca)
- Adakveo (crizanlizumab-tmca)
- Adakveo (crizanlizumab-tmca)
- Adakveo (crizanlizumab-tmca)
- Adakveo (crizanlizumab-tmca)
- Adakveo (crizanlizumab-tmca)
- Adakveo (crizanlizumab-tmca)
- Adakveo (crizanlizumab-tmca)
- Adakveo (crizanlizumab-tmca)
- Adakveo (crizanlizumab-tmca)
- Adakveo (crizanlizumab-tmca) - Archived 7/1/2022
- Adakveo (crizanlizumab-tmca) - Archived on 02/27/2026
- Adakveo (crizanlizumab-tmca) - Archived on 07/01/2024
- Adakveo (crizanlizumab-tmca) - Archived on 07/01/2024
- Adakveo (crizanlizumab-tmca) - Archived on 07/01/2024
- Adakveo (crizanlizumab-tmca) - Archived on 07/01/2024
- Adakveo (crizanlizumab-tmca) - Archived on 1/13/2023
- Adakveo (crizanlizumab-tmca) - Archived on 7/1/2022
- Adakveo (crizanlizumab-tmca) - Archived on 7/1/2022
- Adakveo® (crizanlizumab-tmca intravenous infusion– Novartis)
- Adalimumab (Amjevita, Humira) - Archived 06/30/2023
- Adalimumab (Humira, Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Hyrimoz, Idacio, Yuflyma, Yusimry)
- Adalimumab (Humira, Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Hyrimoz, Idacio, Yuflyma, Yusimry)
- Adalimumab (Humira, Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Hyrimoz, Idacio, Yuflyma, Yusimry)
- Adalimumab (Humira, Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Hyrimoz, Idacio, Yuflyma, Yusimry)
- Adalimumab (Humira, Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Hyrimoz, Idacio, Yuflyma, Yusimry) - Archived 01/01/2025
- Adalimumab (Humira, Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Hyrimoz, Idacio, Yuflyma, Yusimry) - Archived on 01/01/2025
- Adalimumab (Humira, Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Hyrimoz, Idacio, Yuflyma, Yusimry) - Archived on 01/01/2026
- Adalimumab (Humira, Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Hyrimoz, Idacio, Yuflyma, Yusimry) - Archived on 09/27/2025
- Adalimumab (Humira, Amjevita) - Archived 01/01/2024
- Adalimumab (Humira, Hadlima, Hyrimoz and Hulio) - Archived on 01/01/2025
- Adaptive Equipment
- Adaptive Equipment
- Adaptive Equipment
- Adaptive Seating for Special Needs
- Adaptive Seating For Special Needs
- Adaptive Seating for Special Needs
- Adaptive Seating for Special Needs
- Adaptive Seating for Special Needs
- Adbry - Archived on 04/01/2024
- Adbry - Archived on 04/01/2025
- Adbry (tralokinumab-ldrm)
- Adbry (tralokinumab-ldrm)
- Adbry (tralokinumab-ldrm)
- Adbry (tralokinumab-ldrm)
- Adbry (tralokinumab-ldrm)
- Adbry (tralokinumab-ldrm)
- Adbry (tralokinumab-ldrm)
- Adbry (tralokinumab-ldrm) - Archived on 03/31/2025
- Adbry (tralokinumab-ldrm) - Archived on 04/01/2024
- Adbry (tralokinumab-ldrm) - Archived on 04/01/2024
- Adbry (tralokinumab-ldrm) - Archived on 04/01/2025
- Adbry (tralokinumab-ldrm) - Archived on 07/01/2024
- Adbry (tralokinumab-ldrm) - Archived on 07/01/2024
- Adbry (tralokinumab-ldrm) - Archived on 07/01/2024
- Adbry (tralokinumab-ldrm) - Archived on 07/01/2024
- Adbry (tralokinumab-ldrm) - Archived on 10/1/2022
- Adbry (tralokinumab-ldrm) Archive on 02/01/2026
- Adcetris® (brentuximab intravenous infusion – Seattle Genetics)
- Adcetris® (brentuximab intravenous infusion – Seattle Genetics) - Archived on 04/30/2025
- Adcirca (tadalafil)
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addiction Medicine and Buprenorphine Providers
- Addition of Prior Authorization for Part B Therapy
- Additional Dental Handbook Updates for 2016
- Additional Requirements for Fixed Wing and Helicopter Air Ambulance Operators
- Additional Update on CareSource Medicaid Vision Benefit
- Adempas (riociguat)
- Adempas (riociguat)
- Adempas (riociguat) - Archived on 03/07/2025
- Adempas (riociguat) - Archived on 03/07/2025
- Adempas (riociguat) - Archived on 03/10/2025
- ADHD
- ADHD CLINICAL PRACTICE GUIDELINES
- Adstiladrin® (nadofaragene firadenovec-vncg intravesical suspension – Ferring)
- Adstiladrin® (nadofaragene firadenovec-vncg intravesical suspension – Ferring) - Archived on 05/28/2025
- Aduhelm
- Aduhelm (aducanumab-avwa)
- Aduhelm (aducanumab-avwa)
- Aduhelm (aducanumab-avwa)
- Aduhelm (aducanumab-avwa)
- Aduhelm (aducanumab-avwa)
- Aduhelm (aducanumab-avwa)
- Aduhelm (aducanumab-avwa)
- Aduhelm (aducanumab-avwa) - Archived 7/1/2022
- Aduhelm (aducanumab-avwa) - Archived on 1/13/2023
- Aduhelm (aducanumab-avwa) - Archived on 7/1/2022
- Aduhelm (aducanumab-avwa) - Archived on 7/1/2022
- Aduhelm® (aducanumab-avwa intravenous infusion – Biogen/Eisai)
- Adult Developmental Day Treatment
- Adult Developmental Day Treatment Services
- Adult Developmental Day Treatment Services
- Adult Developmental Day Treatment Services
- Adult Growth Hormone Prior Authorization Form
- ADV Rguide(NC2024) NC MP Reference Guide Submission
- ADV Rguide(OH2024) OH MP Reference Guide Submission
- ADV Rguide(WV2024) WV MP Reference Guide Submission
- ADV SalesPresentation(NC2024) 2024 NC MP Sales Presentation FINAL
- ADV SalesPresentation(OH2024) 2024 OH MP Sales Presentation FINAL
- ADV SalesPresentation(WV2024) 2024 WV MP Sales Presentation FINAL
- ADV-BenefitBrochure-NC2023 Benefits Brochure_2022-11-04_508 PROOF FINAL
- ADV-BenefitBrochure(GA2025)_GA MP Benefit Brochure_FINAL
- ADV-BenefitBrochure(GA2026)_2026 GA MP Benefit Brochure
- ADV-BenefitBrochure(NC2025)_NC MP Benefit Brochure_FINAL
- ADV-BenefitBrochure(OH2025)_OH MP Benefit Brochure_FINAL
- ADV-BenefitBrochure(OH2026)_2026 OH MP Benefit Brochure_2025-10-03_PROOF FINAL
- ADV-BenefitBrochure(WV2025)_WV MP Benefit Brochure_FINAL
- ADV-BenefitBrochure(WV2026)_2026 WV MP Benefit Brochure_2025-10-03_PROOF FINAL
- ADV-ChronicBrochure(GA2025)_GA MP Chronic Condition_Elite_Brochure_FINAL
- ADV-ChronicBrochure(GA2026)_2026 GA MP Chronic Condition Elite Brochure_REV1_2025-09-29_PROOF FINAL
- ADV-ChronicBrochure(GA2026)_2026 GA MP Chronic Condition_Elite_Brochure
- ADV-ChronicBrochure(NC2025)_NC MP Chronic Condition_Elite_Brochure_FINAL
- ADV-ChronicBrochure(OH2025)_OH MP Chronic Condition_Elite_Brochure_FINAL
- ADV-ChronicBrochure(OH2026)_2026 OH MP Chronic Condition Elite Brochure_2025-09-30_PROOF FINAL
- ADV-ChronicBrochure(WV2025)_WV MP Chronic Condition_Elite_Brochure_FINAL
- ADV-ChronicBrochure(WV2026)_2026 WV MP Chronic Condition Elite Brochure_2025-09-30_PROOF FINAL
- ADV-DiabetesBrochure(NC2024)_2024 NC MP Diabetes Brochure
- ADV-DiabetesBrochure(OH2024)_2024 OH MP Diabetes Brochure
- ADV-DiabetesBrochure(WV2024)_2024 WV MP Diabetes Brochure
- ADV-ICHRABrochure(GA2026)_2026 GA MP ICHRA Brochure
- ADV-ICHRABrochure(OH2026)_2026 OH MP ICHRA Brochure_2025-10-03_PROOF FINAL
- ADV-ICHRABrochure(WV2026)_2026 WV MP ICHRA Brochure_2025-10-14_FINAL
- ADV-NavigatorPresentation(GA2025)_GA MP Navigator Presentation-FINAL
- ADV-OffExchangeBrochure(GA2026)_2026 GA MP Off Exchange Brochure
- ADV-OffExchangeBrochure(GA2026)_2026 GA MP Off Exchange Brochure
- ADV-OffExchangeBrochure(OH2026)_2026 OH MP Off Exchange Brochure_2025-09-30_PROOF FINAL
- ADV-OffExchangeBrochure(OH2026)_2026 OH MP Off Exchange Brochure_2025-09-30_PROOF FINAL
- ADV-OffExchangeBrochure(OH2026)_2026 OH MP Off Exchange Brochure_REV1_2025-10-16_FINAL
- ADV-Rguide(GA2025) GA MP Reference Guide_FINAL
- ADV-Rguide(GA2026)_2026 GA MP Reference Guide
- ADV-Rguide(GA2026)_2026 GA MP Reference Guide_REV1_2025-09-29_PROOF FINAL
- ADV-Rguide(GA2026)_2026 GA MP Reference Guide_REV2_2025-10-06_PROOF
- ADV-Rguide(NC2025)_NC MP Reference Guide_FINAL
- ADV-Rguide(OH2025)_OH MP Reference Guide_FINAL
- ADV-Rguide(OH2026)_2026 OH MP Reference Guide_2025-09-30_PROOF FINAL
- ADV-Rguide(WV2005)_WV MP Reference Guide_FINAL
- ADV-Rguide(WV2026)_2026 WV MP Reference Guide_2025-09-30_PROOF FINAL
- ADV-SalesPresentation(NC2024)_2024 NC MP Sales Presentation_FINAL_with508
- ADV-SalesPresentation(OH2024)_OH MP Sales Presentation_REV2-FINAL_with508
- ADV-SalesPresentation(WV2024)_2024 WV MP Sales Presentation_FINAL_with508
- ADV-SalesPresentation(WV2025)_WV MP Sales Presentation-FINAL
- ADV-SalesPresentation(WV2026)_WV MP 2026 Navigator Presentation_FINAL
- ADV-SuppBenefitBrochure-NC2023 Supplemental Benefits Brochure_2022-11-29_508
- ADV-SuppBenefitBrochure(GA2025)_GA MP Supplemental Benefit Brochure_FINAL
- ADV-SuppBenefitBrochure(GA2026)_2026 GA MP Supplemental Benefit Brochure
- ADV-SuppBenefitBrochure(NC2025)_NC MP Supplemental Benefit Brochure_FINAL
- ADV-SuppBenefitBrochure(OH2025)_OH MP Supplemental Benefit Brochure_FINAL
- ADV-SuppBenefitBrochure(OH2026)_2026 OH MP Supplemental Benefit Brochure_2025-10-02_PROOF FINAL
- ADV-SuppBenefitBrochure(WV2025)_WV MP Supplemental Benefit Brochure_FINAL
- ADV-SuppBenefitBrochure(WV2026)_2026 WV MP Supplemental Benefit Brochure_2025-10-14_FINAL
- Advance Directives
- Advanced Diagnostic Imaging Services
- Advate® (Antihemophilic Factor intravenous infusion – Baxalta/Takeda)
- Adynovate® (Antihemophilic Factor PEGylated intravenous infusion – Baxalta/Takeda)
- Adzynma
- Adzynma (ADAMT S13, recombinant-krhn)
- Adzynma (ADAMT S13, recombinant-krhn)
- Adzynma (ADAMT S13, recombinant-krhn)
- Adzynma (ADAMT S13, recombinant-krhn)
- Adzynma (ADAMT S13, recombinant-krhn)
- Adzynma (ADAMTS13, recombinant-krhn)
- Adzynma (ADAMTS13, recombinant-krhn)
- Adzynma (ADAMTS13, recombinant-krhn)
- Adzynma (ADAMTS13, recombinant-krhn)
- Adzynma (ADAMTS13, recombinant-krhn)
- Adzynma (ADAMTS13, recombinant-krhn)
- Adzynma™ (ADAMTS13 recombinant-krhn intravenous infusion − Takeda)
- AFINITOR (everolimus)
- Aflibercept (Eylea, Eylea HD, Pavblu)
- Aflibercept (Eylea, Eylea HD, Pavblu)
- Aflibercept (Eylea, Eylea HD, Pavblu)
- Aflibercept (Eylea, Eylea HD, Pavblu)
- Aflibercept (Eylea, Eylea HD, Pavblu)
- Aflibercept (Eylea, Eylea HD, Pavblu)
- Aflibercept (Eylea, Eylea HD, Pavblu)
- Aflibercept (Eylea, Eylea HD, Pavblu) Archive on 02/01/2026
- Afstyla® (Antihemophilic Factor single chain intravenous infusion – CSL Behring)
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice (AMA)
- Against Medical Advice TrueCare
- Agamree (vamorolone)
- Agamree (vamorolone)
- Agamree (vamorolone)
- Agamree (vamorolone)
- Agamree (vamorolone)
- Aimovig - Archived on 06/19/2023
- Aimovig (erenumab-aooe)
- Aimovig (erenumab-aooe)
- Aimovig (erenumab-aooe)
- Aimovig (erenumab-aooe)
- Aimovig (erenumab-aooe)
- Aimovig (erenumab-aooe)
- Aimovig (erenumab-aooe)
- Aimovig (erenumab-aooe)
- Aimovig (erenumab-aooe)
- Aimovig (erenumab-aooe)
- Aimovig (erenumab-aooe)
- Aimovig (erenumab-aooe)
- Aimovig (erenumab-aooe)
- Aimovig (erenumab-aooe) - Archive on 10/0/2024
- Aimovig (erenumab-aooe) - Archived 08/23/2023
- Aimovig (erenumab-aooe) - Archived 10/1/2022
- Aimovig (erenumab-aooe) - Archived 9/30/2022
- Aimovig (erenumab-aooe) - Archived on 06/19/2023
- Aimovig (erenumab-aooe) - Archived on 06/19/2023
- Aimovig (erenumab-aooe) - Archived on 06/19/2023
- Aimovig (erenumab-aooe) - Archived on 07/01/2023
- Aimovig (erenumab-aooe) - Archived on 10/1/2022
- Aimovig (erenumab-aooe) -Archived on 08/23/2023
- Air Ambulance Transportation
- Air Ambulance Transportation
- Airway Clearance Devices
- Airway Clearance Devices
- Airway Clearance Devices
- Airway Clearance Devices
- Airway Clearance Devices
- Airway Clearance Devices
- Airway Clearance Devices
- Airway Clearance Devices
- Airway Clearance Devices
- Ajovy - Archived 7/28/2023
- Ajovy (fremanezumab-vfrm)
- Ajovy (fremanezumab-vfrm)
- Ajovy (fremanezumab-vfrm)
- Ajovy (fremanezumab-vfrm)
- Ajovy (fremanezumab-vfrm)
- Ajovy (fremanezumab-vfrm)
- Ajovy (fremanezumab-vfrm)
- Ajovy (fremanezumab-vfrm)
- Ajovy (fremanezumab-vfrm)
- Ajovy (fremanezumab-vfrm) - Archive on 10/0/2024
- Ajovy (fremanezumab-vfrm) - Archived 01/17/2023
- Ajovy (fremanezumab-vfrm) - Archived 01/17/2023
- Ajovy (fremanezumab-vfrm) - Archived 10/1/2022
- Ajovy (fremanezumab-vfrm) - Archived 9/30/2022
- Ajovy (fremanezumab-vfrm) - Archived on 01/01/2026
- Ajovy (fremanezumab-vfrm) - Archived on 06/03/2025
- Ajovy (fremanezumab-vfrm) - Archived on 06/03/2025
- Ajovy (fremanezumab-vfrm) - Archived on 10/1/2022
- Aldurazyme
- Aldurazyme - Archived on 07/01/2024
- ALDURAZYME (laronidase)
- Aldurazyme (laronidase)
- Aldurazyme (laronidase)
- Aldurazyme (laronidase)
- Aldurazyme (laronidase)
- Aldurazyme (laronidase)
- Aldurazyme (laronidase)
- Aldurazyme (laronidase)
- Aldurazyme (laronidase)
- Aldurazyme (laronidase)
- Aldurazyme (laronidase)
- Aldurazyme (laronidase) - Archived on 07/01/2024
- Aldurazyme (laronidase) - Archived on 07/01/2024
- Aldurazyme (laronidase) - Archived on 07/01/2024
- Aldurazyme (laronidase) - Archived on 07/01/2024
- Aldurazyme® (laronidase intravenous infusion – Genzyme)
- Aldurazyme® (laronidase intravenous infusion – Genzyme) - Archived on 05/28/2025
- ALERT: MITS Scheduled Downtime October 10 6PM until October 14 6AM
- Alimta (pemetrexed intravenous infusion – Eli Lilly, generics)
- Aliqopa® (copanlisib intravenous infusion – Bayer)
- All Patient Refined Diagnosis Related Groups (“APR-DRG”)
- All Patient Refined Diagnosis Related Groups (APR-DRG)
- Allergy Testing and Allergen Immunotherapy
- Allergy Testing and Allergen Immunotherapy
- Allergy Testing and Allergen Immunotherapy
- Allergy Testing and Allergen Immunotherapy
- Allergy Testing and Allergen Immunotherapy
- Allergy Testing and Allergen Immunotherapy
- Allergy Testing and Allergen Immunotherapy
- Allergy Testing and Allergen Immunotherapy
- Allergy Testing and Allergen Immunotherapy
- Allergy Testing and Allergen Immunotherapy
- Alpha 1-Proteinase Inhibitor Injection
- Alpha 1-Proteinase Inhibitor Injection
- Alpha-1 Proteinase Inhibitors
- Alpha-1 Proteinase Inhibitors
- Alpha1-Proteinase Inhibitor (Aralast NP, Glassia, Prolastin C, Zemaira [human])
- Alpha1-Proteinase Inhibitor (Aralast NP, Glassia, Prolastin C, Zemaira [human])
- Alpha1-Proteinase Inhibitor (Aralast NP, Glassia, Prolastin C, Zemaira [human])
- Alpha1-Proteinase Inhibitor (Aralast NP, Glassia, Prolastin C, Zemaira [human])
- Alpha1-Proteinase Inhibitor (Aralast NP, Glassia, Prolastin C, Zemaira [human])
- Alpha1-Proteinase Inhibitor (Aralast NP, Glassia, Prolastin C, Zemaira [human])
- Alpha1-Proteinase Inhibitor (Aralast NP, Glassia, Prolastin C, Zemaira [human])
- Alpha1-Proteinase Inhibitor (Aralast NP, Glassia, Prolastin C, Zemaira [human])
- Alpha1-Proteinase Inhibitor (Aralast NP, Glassia, Prolastin C, Zemaira [human])
- Alpha1-Proteinase Inhibitor (Aralast NP, Glassia, Prolastin C, Zemaira [human])
- Alpha1-Proteinase Inhibitor (Aralast NP, Glassia, Prolastin C, Zemaira [human]) - Archived on 07/01/2025
- Alpha1-Proteinase Inhibitors
- Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin C, Zemaira [human]) - Archived 01/01/2024
- Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin C, Zemaira [human]) - Archived 01/01/2024
- Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin C, Zemaira [human]) - Archived 01/01/2024
- Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin C, Zemaira [human]) - Archived on 04/01/2024
- Alphanate (Antihemophilic Factor/von Willebrand Factor Complex [human] intravenous infusion – Grifols)
- AlphaNine SD (Coagulation Factor IX [plasma-derived] intravenous infusion – Grifols)
- Alprolix® (Coagulation Factor IX [recombinant] Fc fusion protein intravenous infusion – Bioverativ/Sanofi)
- Altuviiio™ (antihemophilic factor [recombinant] Fc-VWF-XTEN fusion protein-ehtl intravenous infusion − Bioverativ/Sanofi)
- Alunbrig (brigatinib)
- Alunbrig (brigatinib)
- Alunbrig (brigatinib)
- Alyftrek (vanzacaftor/tezacaftor/deutivacaftor)
- Alyftrek (vanzacaftor/tezacaftor/deutivacaftor)
- Alyftrek (vanzacaftor/tezacaftor/deutivacaftor)
- Alyftrek (vanzacaftor/tezacaftor/deutivacaftor)
- Alyftrek (vanzacaftor/tezacaftor/deutivacaftor)
- Alyglo™ (immune globulin intravenous solution-stwk – GC Biopharma)
- Alymsys® (bevacizumab-maly intravenous infusion – Amneal)
- Alzheimer's
- AM-EXC-P-337204 Cultural Competency Training
- AM-EXCM-0589a-V.7_2018-in-wv-marketplace-formulary
- AM-EXCM-0786 Internal Appeal Request Form
- AM-EXCM-0886 E-cig_vaping Brochure
- AM-EXCP-0186-2017-Marketplace-Dental-Quick-Reference-Guide
- AM-EXCP-0188-Exchange-of-Info-Checklist-NN
- AM-EXCP-0200_Notification-of-Clinical-Edit-Errors-Corrective-Plan
- AM-EXCP-0212_Well-Child Care
- AM-EXCP-0260 Marketplace Prior Authorization List Updates Network Notification
- AM-EXCP-0270 Facility Claim Cost Share Network Notification
- AM-EXCP-0286 After-Hours PCP Coverage_Final
- AM-EXCP-0301 Upcoming Marketplace 2020 PA List Changes
- AM-EXCP-0303 Holiday Checkwrite Delay
- am-marketplace-hipaa-authorization-form
- AMA_COVID-19 CPT Coding Guidance
- AMA_COVID-19 CPT Reporting and Testing
- Ambrisentan (Letairis)
- Ambulance Overpayments and Incorrect Payments Recovery OH-P-1525
- Ambulatory Blood Pressure Monitoring
- AMDG Opioid Guideline 2015
- AMDG Opioid Guideline Taper Washington 2015
- American Rescue Plan FAQ
- Americans with Disabilities Act (ADA) Compliance Network Notification
- Amevive - Archived on 03/07/2025
- Amevive (alefacept)
- Amevive (alefacept)
- Amevive (alefacept)
- Amevive (alefacept)
- Amevive (alefacept)
- Amevive (alefacept)
- Amevive (alefacept)
- Amevive (alefacept)
- Amevive (alefacept)
- Amondys 45 (casimersen)
- Amondys 45
- Amondys 45
- Amondys 45 (casimersen)
- Amondys 45 (casimersen)
- Amondys 45 (casimersen)
- Amondys 45 (casimersen)
- Amondys 45 (casimersen)
- Amondys 45 (casimersen)
- Amondys 45 (casimersen) - Archived 7/1/2022
- Amondys 45 (casimersen) - Archived on 02/27/2026
- Amondys 45 (casimersen) - Archived on 4/21/2023